Free speech, intellectual integrity and professional respect won an important victory last week when the Accreditation Council for Continuing Medical Education reversed a year-old policy and decided that continuing medical education credits can be granted for attending scientific presentations made by scientists who work for drug companies.

It turns out that the tender ears of physicians won't be tarnished, and their delicate moral compasses won't be thrown out of kilter, by hearing directly from investigators employed by drug companies that have designed and conducted clinical trials.